BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

RXi Pharmaceuticals 

1500 West Park Drive
Suite 210
Westborough  Massachusetts  01581  U.S.A.
Phone: 508-767-3861 Fax: 508-767-3862


SEARCH JOBS








 Company News
RXi Pharmaceuticals (RXII) Reports Full Year 2013 Financial Results 3/31/2014 6:22:40 AM    More...
RXi Pharmaceuticals (RXII) Announces Upcoming Presentations 3/14/2014 6:32:48 AM    More...
RXi Pharmaceuticals (RXII) Granted Key Patent Related To Self-Delivering Technology For The Treatment Of Fibrotic Disorders 3/5/2014 10:36:27 AM    More...
RXi Pharmaceuticals (RXII) To Present At The 26th Annual ROTH Conference 3/4/2014 6:48:45 AM    More...
RXi Pharmaceuticals (RXII) To Present At The 24th Annual Wall Street Analyst Forum 2/24/2014 6:27:56 AM    More...
RXi Pharmaceuticals (RXII) Announces Listing On NASDAQ Capital Market 2/11/2014 10:12:22 AM    More...
RXi Pharmaceuticals (RXII) To Present At The 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/3/2014 6:40:30 AM    More...
RXi Pharmaceuticals (RXII) Receives US Notice Of Allowance For A Key Patent Relating To Its Self-Delivering Technology With Sd-Rxrnas Targeting CTGF, Including RXI-109, For The Treatment Of Fibrotic Disorders 1/14/2014 10:43:54 AM    More...
RXi Pharmaceuticals (RXII) To Present At The Biotech Showcase™ 2014 1/6/2014 6:16:20 AM    More...
RXi Pharmaceuticals (RXII) Announces mRNA Data Of An Additional Cohort In The Second Phase 1 Multi-Dose Study With RXI-109, Extending The Dose Response Following Treatment In The Initial 2-Week Period 12/4/2013 11:05:02 AM    More...
12345678910...

//-->